Ｄｅｌｔａ－Ｆｌｙ Ｐｈａｒｍａの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/16 | 1,195 | 1,235 | 1,179 | 1,221 | +41 | +3.5% | 185,700 |
| 2022/03/15 | 1,168 | 1,192 | 1,131 | 1,180 | -9 | -0.8% | 130,900 |
| 2022/03/14 | 1,174 | 1,207 | 1,144 | 1,189 | +6 | +0.5% | 181,800 |
| 2022/03/11 | 1,230 | 1,260 | 1,150 | 1,183 | -17 | -1.4% | 562,000 |
| 2022/03/10 | 1,202 | 1,230 | 1,104 | 1,200 | +28 | +2.4% | 703,100 |
| 2022/03/09 | 1,388 | 1,404 | 1,172 | 1,172 | -400 | -25.4% | 1,261,200 |
| 2022/03/08 | 1,568 | 1,636 | 1,547 | 1,572 | -4 | -0.3% | 193,200 |
| 2022/03/07 | 1,605 | 1,615 | 1,550 | 1,576 | -85 | -5.1% | 206,800 |
| 2022/03/04 | 1,730 | 1,730 | 1,622 | 1,661 | -98 | -5.6% | 299,500 |
| 2022/03/03 | 1,830 | 1,862 | 1,735 | 1,759 | -42 | -2.3% | 331,700 |
| 2022/03/02 | 1,759 | 1,827 | 1,729 | 1,801 | +2 | +0.1% | 217,800 |
| 2022/03/01 | 1,755 | 1,844 | 1,751 | 1,799 | +60 | +3.5% | 196,800 |
| 2022/02/28 | 1,622 | 1,755 | 1,619 | 1,739 | +52 | +3.1% | 242,200 |
| 2022/02/25 | 1,552 | 1,705 | 1,551 | 1,687 | +205 | +13.8% | 342,000 |
| 2022/02/24 | 1,572 | 1,623 | 1,449 | 1,482 | -115 | -7.2% | 440,900 |
| 2022/02/22 | 1,570 | 1,625 | 1,520 | 1,597 | -13 | -0.8% | 204,700 |
| 2022/02/21 | 1,560 | 1,642 | 1,560 | 1,610 | -20 | -1.2% | 181,800 |
| 2022/02/18 | 1,541 | 1,639 | 1,501 | 1,630 | +33 | +2.1% | 196,200 |
| 2022/02/17 | 1,734 | 1,734 | 1,496 | 1,597 | -168 | -9.5% | 538,700 |
| 2022/02/16 | 1,668 | 1,873 | 1,660 | 1,765 | +154 | +9.6% | 543,800 |
| 2022/02/15 | 1,551 | 1,629 | 1,503 | 1,611 | +69 | +4.5% | 244,100 |
| 2022/02/14 | 1,757 | 1,757 | 1,535 | 1,542 | -288 | -15.7% | 542,000 |
| 2022/02/10 | 1,847 | 1,923 | 1,798 | 1,830 | +43 | +2.4% | 268,700 |
| 2022/02/09 | 1,760 | 1,818 | 1,680 | 1,787 | +63 | +3.7% | 246,300 |
| 2022/02/08 | 1,746 | 1,785 | 1,691 | 1,724 | -61 | -3.4% | 322,700 |
| 2022/02/07 | 1,912 | 2,033 | 1,766 | 1,785 | -87 | -4.6% | 999,100 |
| 2022/02/04 | 1,940 | 1,968 | 1,812 | 1,872 | -108 | -5.5% | 1,053,500 |
| 2022/02/03 | 1,688 | 1,995 | 1,656 | 1,980 | +240 | +13.8% | 1,936,000 |
| 2022/02/02 | 1,467 | 1,790 | 1,425 | 1,740 | +250 | +16.8% | 2,629,100 |
| 2022/02/01 | 1,422 | 1,490 | 1,352 | 1,490 | +300 | +25.2% | 734,800 |
| 2022/01/31 | 1,161 | 1,214 | 1,161 | 1,190 | +29 | +2.5% | 90,400 |
| 2022/01/28 | 1,185 | 1,228 | 1,142 | 1,161 | -24 | -2% | 151,200 |
| 2022/01/27 | 1,247 | 1,264 | 1,167 | 1,185 | -62 | -5% | 138,700 |
| 2022/01/26 | 1,209 | 1,264 | 1,189 | 1,247 | +44 | +3.7% | 81,500 |
| 2022/01/25 | 1,291 | 1,351 | 1,183 | 1,203 | -118 | -8.9% | 270,700 |
| 2022/01/24 | 1,310 | 1,329 | 1,236 | 1,321 | -9 | -0.7% | 198,800 |
| 2022/01/21 | 1,353 | 1,360 | 1,319 | 1,330 | -50 | -3.6% | 100,300 |
| 2022/01/20 | 1,442 | 1,501 | 1,350 | 1,380 | -62 | -4.3% | 165,000 |
| 2022/01/19 | 1,427 | 1,479 | 1,414 | 1,442 | -1 | -0.1% | 116,900 |
| 2022/01/18 | 1,486 | 1,509 | 1,430 | 1,443 | -42 | -2.8% | 91,600 |
| 2022/01/17 | 1,547 | 1,554 | 1,474 | 1,485 | -35 | -2.3% | 76,800 |
| 2022/01/14 | 1,535 | 1,535 | 1,475 | 1,520 | -55 | -3.5% | 125,200 |
| 2022/01/13 | 1,543 | 1,575 | 1,490 | 1,575 | +11 | +0.7% | 66,500 |
| 2022/01/12 | 1,560 | 1,600 | 1,528 | 1,564 | +9 | +0.6% | 67,400 |
| 2022/01/11 | 1,453 | 1,569 | 1,429 | 1,555 | +119 | +8.3% | 138,800 |
| 2022/01/07 | 1,497 | 1,540 | 1,382 | 1,436 | -14 | -1% | 132,900 |
| 2022/01/06 | 1,471 | 1,496 | 1,438 | 1,450 | -46 | -3.1% | 98,400 |
| 2022/01/05 | 1,576 | 1,594 | 1,471 | 1,496 | -82 | -5.2% | 142,200 |
| 2022/01/04 | 1,515 | 1,589 | 1,515 | 1,578 | +91 | +6.1% | 124,700 |
| 2021/12/30 | 1,442 | 1,515 | 1,442 | 1,487 | +23 | +1.6% | 111,500 |
801～
850
件表示中 / 1632件
類似銘柄と比較する
現在ご覧いただいている「ＤＥＬＴＡ－Ｐ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＤＥＬＴＡ－Ｐ | 63,100円 | - | - | 0.00% | - | 25.07倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
| サイフューズ | 84,000円 | +459.3% | - | 0.00% | - | 2.80倍 |
|
バイオ３Ｄプリンタを開発、自家細胞製品の製造受託も。臓器など再生医療等製品を臨床開発中 |
| ソレイジア | 3,100円 | +311.4% | - | 0.00% | - | 5.95倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
| モダリス | 8,500円 | - | - | 0.00% | - | 1.85倍 |
|
遺伝子治療薬の創薬ベンチャー、ＤＮＡ切断しないエピゲノム編集に強み。研究開発中心は米国 |
| 日ケミファ | 151,900円 | +7.5% | -77.4% | 3.29% | 36.54倍 | 0.29倍 |
|
後発薬中堅、検査薬事業が第２の柱に。提携含めた新薬開発、ベトナムなど海外事業を中期強化 |
市場注目の銘柄
チャート関連のコラム
